Phoenix Biotech Acquisition Corp.
NASDAQ: PBAX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Christopher B. Ehrlich
- Headquarters
- Oakland, United States
- IPO year
- 2021
- Market cap
- $36.5M
Loading PBAX…
Loading profile data…Frequently asked questions about PBAX
What does Phoenix Biotech Acquisition Corp. (PBAX) do?
Phoenix Biotech Acquisition Corp. currently lacks substantial business operations. The company's primary objective is to complete a strategic business combination, such as a merger, asset acquisition, share exchange, or other form of reorganization, with one or more suitable enterprises. Its focus is on identifying and integrating with a firm en...
Where does PBAX trade?
Phoenix Biotech Acquisition Corp. (PBAX) trades on the NASDAQ Global Market.
What sector is PBAX in?
Phoenix Biotech Acquisition Corp. (PBAX) operates in the Financial Services sector, specifically in the Shell Companies industry.
Who is the CEO of Phoenix Biotech Acquisition Corp.?
Christopher B. Ehrlich is the chief executive officer of Phoenix Biotech Acquisition Corp. (PBAX).
Where is Phoenix Biotech Acquisition Corp. headquartered?
Phoenix Biotech Acquisition Corp. is headquartered in United States.
Does PBAX pay a dividend?
Phoenix Biotech Acquisition Corp. (PBAX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PBAX go public?
Phoenix Biotech Acquisition Corp. (PBAX) completed its initial public offering in 2021.